Sunday, December 22, 2024
Home Tags Dose-dependent

Tag: Dose-dependent

AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol:...

Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233). It is an investigational antisense medicine designed...